Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review May 8, 2024May 8, 2024
Completion of investment by Life Biosciences LLC and capital raising update April 8, 2019August 16, 2022